- CA$1.33m
- CA$1.34m
- CA$0.13m
Annual income statement for Arway, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2023 August 31st | 2024 August 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 0.06 | 0.127 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Total Operating Expenses | 8.17 | 2.55 |
| Operating Profit | -8.11 | -2.43 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Net Income Before Taxes | -8.15 | -2.43 |
| Net Income After Taxes | -8.15 | -2.43 |
| Net Income Before Extraordinary Items | ||
| Net Income | -8.15 | -2.43 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -8.15 | -2.43 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.2 | -0.061 |